Cigarette smoking is strongly related to the development of atherosclerosis, including coronary artery disease, and it has a number of other potentially adverse effects on the cardiovascular system. Some of these are mediated through the effect of nicotine on thrombosis, arrhythmias,' and platelet function. 23 Others are mediated through the effect of raised carboxyhaemoglobin and nicotine levels which may jeopardise left ventricular function4 as well as lowering the ventricular fibrillation threshold.5
Most early survivors of myocardial infarction have extensive underlying coronary atherosclerosis. The major determinant of prognosis after myocardial infarction, at least for the first one or two years, is the extent of damage to the myocardium. Is it reasonable therefore to expect cessation of smoking to improve prognosis after myocardial infarction or are the potential benefits negatived by irreversible atherosclerosis and myocardial scarring?
Considerable data are available to answer this question. It should be stressed at the outset that there have been no randomised control trials of stopping smoking after myocardial infarction. This raises the question of the comparability of those who stop smoking after myocardial infarction with those who continue. Nevertheless, the extent and consistency of available evidence, and the lack of contradictory evidence, are notable. Even without such evidence a randomised control trial of smoking cessation would be ethically dubious and impractical to perform.
Subsequent cigarette smoking habits and mortality
Although cigarette smoking at the time of initial myocardial infarction does not appear to influence subsequent prognosis,6 7 there is substantial evidence that smoking habits after myocardial infarction have an important influence on subsequent morbidity and mortality.
The Coronary Drug Project8 and the Newcastle9 and Scottish'0 clofibrate trials found a higher mortality in smokers at entry to their studies compared with non-smokers. The coronary mortality ratio of smokers to non-smokers in the Coronary Drug Project was 1.25 while the ratio for sudden deaths, deaths from fatal and further non-fatal myocardial infarction combined was 1.33 and 1*70 for the Newcastle and Scottish smokers compared with non-smokers.
It is important to note that the Coronary Drug Project and the Newcastle and Scottish clofibrate studies related subsequent morbidity and mortality to smoking at entry to the study. In these three studies entry occurred at a variable time after infarction and in some cases not for several months. In the case of the Coronary Drug Project a few years may have elapsed before entry. These studies were not designed specifically to measure the effect of postmyocardial infarction cigarette smoking on subsequent morbidity or mortality. This and the wide variation in time of entry to the study may have resulted in a less precise measure of benefit.
In a study designed to measure the effect of subsequent smoking on cardiovascular and all-causes mortality, Salonen" I recorded smoking habits six months after initial myocardial infarction. All-causes and cardiovascular mortality were significantly higher in smokers compared with non-smokers with risk ratios of 1.7 and 16, respectively, over a three year period.
Wilhelmssonet al., I2 in a study of 564 male patients who survived a first myocardial infarction and whose smoking habits were measured three months after entry, reported a halving in cardiovascular mortality and in subsequent non-fatal myocardial infarction over a two year period in those who stopped smoking.
In a further paper from this group published in this issue, Aberg et al. 13 Authors who reported on mode of death in relation to subsequent smoking found no difference in the ratio of sudden death to deaths from fresh myocardial infarction between smoking and non-smoking decedents.17 22 It also seems that the adverse effect of smoking after infarction is independent of other primary and secondary risk factors, including Type A personality, hyperlipidaemia,l8 hypertension, and severity of first myocardial infarction. 7 Not all reports commented on the dose related effect of smoking during follow-up. Salonen1' found that the adverse effects of follow-up smoking in coronary patients were dose related. Vlietstra et al.. ,9 in their arteriography study, also noted a dose related effect. In our five year study14 we noted no difference in mortality between those who stopped smoking and those who reduced their smoking volume by more than half, thus suggesting benefits from reducing the volume of smoking.
According Irfluence of cigarette smoking on morbidity and mortality after myocardial infarction poor compliance in relation to smoking advice. An awareness of these adverse factors is important if we are to achieve optimum success in encouraging patients to stop smoking. The likelihood of permanent success is greater in older patients, in lighter rather than heavier smokers, non-inhalers rather than inhalers, in those who use filter tips, in those who have previously stopped or tried to stop, and particularly in those subjects who are well motivated.3' 3
In patients with myocardial infarction, intervention in relation to smoking must start from the time of admission to the coronary care unit. All health personnel concerned with the care of the infarct patient can play a part in counselling and influencing the patient. The coronary care nurse has a role as have the resident medical staff, physiotherapist, dietitian, social worker, and above all the physician or cardiologist in charge of the patient. Printed material containing information on the importance of cigarette smoking as a risk factor, on possible mechanisms, and on techniques of stopping smoking, is invaluable. Maintaining contact with the patient after discharge by providing rehabilitation and secondary prevention clinics can be crucial in long term management. This also applies to cessation techniques in healthy subjects.3'
The importance of social support in smoking cessation is clear.36 Social support includes the cooperation and encouragement of relatives and friends, including the avoidance of smoking in the company of the subject. The spouse has an important rolenagging and "policing" lead to poor cessation results while encouragement, support, and co-operation evoke good results. 37 Patients 
